Yahoo Malaysia Web Search

Search results

  1. We came to Biogen to solve the unsolvable. We stay to create new possibilities and grow together. We work fearlessly and go beyond because we care deeply about making a difference and changing lives.

    • Careers

      We drive innovation to defeat some of the most complex and...

    • Pipeline

      With a strong focus on difficult-to-treat diseases, our...

    • Company

      Community Guidelines. Biogen is a leading global...

    • News Releases

      The Investor Relations website contains information about...

  2. www.biogen.com › companyCompany | Biogen

    Community Guidelines. Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity ...

  3. The potential to transform the lives of patients drives us at Biogen. Alzheimer’s Disease and Dementia. Our world-class neurology research and development organization is pushing toward novel approaches for previously intractable neurodegenerative conditions such as Alzheimer’s disease.

  4. www.youtube.com › biogenBiogen - YouTube

    Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our ...

  5. www.linkedin.com › company › biogen-Biogen | LinkedIn

    96 3 Comments. Biogen | 998,741 followers on LinkedIn. Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform...

  6. Gain important insights of BIOGENTECH (M) SDN BHD. Explore their company registration information, banking payment history, litigation, and trade references to make informed decisions about extending credit or engaging in business transactions with this company.

  7. 22 Mei 2024 · Biogen Inc. agreed to acquire Human Immunology Biosciences Inc. for as much as $1.8 billion in a deal aimed at bolstering the biotechnology giant’s pipeline of immune disease treatments.